secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2022-03-18T23:59:59+00:00
Accession:  0001193125-22-079575
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead shareholders reject advisory pay plan and director comp plan at annual meeting
--------------------------------------------------------------------------------

- Advisory vote on executive compensation: 54.8M against vs 14.2M for; proposal fails.
- Non-Employee Director Compensation Plan: 52.5M against vs 16.0M for; proposal fails.
- Three directors (Ferrari, Perry, Waddill) received majority AGAINST votes (44.4M, 39.8M, 42.7M resp.).
- Ratification of auditors (Rose Snyder & Jacobs) passed with 87.2M votes for.
- Approx. 20.2M broker non-votes on all proposals except auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000119312522079575/0001193125-22-079575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000119312522079575/d321053d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-079575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer